NLRP3 inflammasome dysregulation in chronic bacterial infections: mechanistic insights into treatment failure and relapse.
Abstract
Chronic and recurrent bacterial infections are a significant clinical issue despite the development of antimicrobial treatment. It is increasingly being shown that chronic host-based inflammatory dysregulation is also an integral cause of treatment failure and persistence of illness, and not just the consequence of microbial resistance. The NLRP3 inflammasome presents an important integrated platform linking tissue destruction, metabolic strain, and microbial detection to augmented inflammatory reactions. The ultimate goal of the review is to assess chronic bacterial infection as an inflammatory resolution dysfunction, and the example of persistent NLRP3 inflammasome dysregulation and the therapeutic consequences. In this review, the existing data on the canonical and non-canonical pathways of NLRP3 activation is summarized and the interplay between metabolic reprogramming, ionic flux, mitochondrial dysfunction, and impaired autophagy are all thought to contribute to the lowered activation thresholds in chronic infection. The disease-specific pathology of the prolonged IL-1β and IL-18 generation, destabilisation of the barricade and inflammatory feedback prolongation are common pathological themes in contexts like granulomatous lung disease, intracellular persistence syndromes, biofilm-associated infections and chronic airway colonisation. Inflammasome permissiveness and resolution are exacerbated by immunometabolic changes and microbiome imbalance.